INBX vs AAPL: Which Stock is Better?
Side-by-side comparison of Inhibrx Biosciences Inc and Apple Inc in 2026
INBX
Inhibrx Biosciences Inc
$83.07
AAPL
Apple Inc
$265.80
Key Metrics Comparison
| Metric | INBX | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.22B | N/A | INBX |
| P/E Ratio | N/A | 33.68 | AAPL |
| EPS (TTM) | $N/A | $7.91 | AAPL |
| Revenue Growth | -1.0% | 0.2% | AAPL |
| Gross Margin | -8594.5% | 47.3% | AAPL |
Analyze INBX
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INBX or AAPL a better investment?
Comparing INBX and AAPL: Inhibrx Biosciences Inc has a market cap of $1.22B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INBX and AAPL?
INBX (Inhibrx Biosciences Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INBX or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INBX or AAPL?
AAPL has higher revenue growth at 0.2% vs -1.0% for INBX.
Which company is more profitable: INBX or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.3% compared to -8594.5% for INBX.
Which is the larger company: INBX or AAPL?
Inhibrx Biosciences Inc (INBX) is larger with a market cap of $1.22B compared to N/A for AAPL.
Should I buy INBX or AAPL in 2026?
Both INBX and AAPL have investment merit. INBX trades at $83.07 while AAPL trades at $265.80. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INBX and AAPL stock?
Key differences: Market Cap ($1.22B vs N/A), P/E Ratio (N/A vs 33.7x), Revenue Growth (-1.0% vs 0.2%), Gross Margin (-8594.5% vs 47.3%).